We are live on ! Find out more
MLL

Moody Lynn & Lieberson Portfolio holdings

AUM $1.9B
1-Year Est. Return 27.82%
This Fund
S&P 500
This Quarter Est. Return
+12.48%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$1.01B
AUM Growth
+$88.5M
Cap. Flow
+$18.6M
Cap. Flow %
1.85%
Top 10 Hldgs %
34.11%
Holding
214
New
29
Increased
41
Reduced
76
Closed
20

Top Buys

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$32.8M
2
HUM icon
Humana
HUM
+$7.8M
3
SIVB
SVB Financial Group
SIVB
+$6.63M
4
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$6.62M
5
NKE icon
Nike
NKE
+$5.46M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.2M
2
AMT icon
American Tower
AMT
+$8.84M
3
NVDA icon
NVIDIA
NVDA
+$5.96M
4
APD icon
Air Products & Chemicals
APD
+$5.94M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.68M

Sector Composition

Rank Sector Weight
1 Technology 21.87%
2 Healthcare 17.55%
3 Financials 14.24%
4 Consumer Discretionary 10.72%
5 Industrials 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BJ icon
176
BJs Wholesale Club
BJ
$12.3B
$229K 0.02%
+5,520
New +$228K
CPRT icon
177
Copart
CPRT
$27.5B
$225K 0.02%
+8,576
New +$208K
YUMC icon
178
Yum China
YUMC
$16.3B
$222K 0.02%
4,193
– –
CHKP icon
179
Check Point Software Technologies
CHKP
$13.1B
$220K 0.02%
+1,825
New +$223K
GPC icon
180
Genuine Parts
GPC
$18.7B
$218K 0.02%
+2,287
New +$213K
CI icon
181
Cigna
CI
$74.6B
$211K 0.02%
1,244
-125
-9% -$22K
LRCX icon
182
Lam Research
LRCX
$390B
$211K 0.02%
6,350
– –
ALL icon
183
Allstate
ALL
$67.5B
$209K 0.02%
2,216
– –
MVF
184
DELISTED
BlackRock MuniVest Fund
MVF
$104K 0.01%
12,000
– –
ALC icon
185
Alcon
ALC
$35B
– –
-58,825
Closed -$3.37M
ALB icon
186
Albemarle
ALB
$15.5B
– –
-51,035
Closed -$3.94M
BRK.A icon
187
Berkshire Hathaway Class A
BRK.A
$1.12T
– –
-1
Closed -$267K
CCI icon
188
Crown Castle
CCI
$32.2B
– –
-31,543
Closed -$5.28M
GDX icon
189
VanEck Gold Miners ETF
GDX
$27.4B
– –
-107,310
Closed -$3.94M
GILD icon
190
Gilead Sciences
GILD
$165B
– –
-2,928
Closed -$225K
HQY icon
191
HealthEquity
HQY
$8.75B
– –
-27,139
Closed -$1.59M
MS icon
192
Morgan Stanley
MS
$340B
– –
-13,640
Closed -$659K
REGN icon
193
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-9,108
Closed -$5.68M
ROP icon
194
Roper Technologies
ROP
$39.8B
– –
-11,087
Closed -$4.3M
STZ icon
195
Constellation Brands
STZ
$23.2B
– –
-16,595
Closed -$2.9M
T icon
196
AT&T
T
$163B
– –
-35,752
Closed -$816K
UL icon
197
Unilever
UL
$136B
– –
-3,907
Closed -$241K
ULTA icon
198
Ulta Beauty
ULTA
$24.3B
– –
-1,425
Closed -$290K
VFC icon
199
VF Corp
VFC
$5.89B
– –
-5,879
Closed -$358K
VRTX icon
200
Vertex Pharmaceuticals
VRTX
$126B
– –
-14,938
Closed -$4.34M
5 6 7
8
9

Similar funds

EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.9B AUM 2.22% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return

Moody Lynn & Lieberson's Q3 2020 Portfolio in Review

As of Q3 2020, Moody Lynn & Lieberson held 214 positions worth $1.01B, up 9.6% from $921M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Moody Lynn & Lieberson's Q3 2020 filing shows 29 new, 41 increased, 76 reduced and 20 closed positions. Its largest new stake was Humana: 19,386 shares worth $8.02M. The largest sale was Microsoft, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Moody Lynn & Lieberson's largest Q3 2020 buy was Humana: 19,386 shares worth $8.02M.
  • Moody Lynn & Lieberson added most to NextEra Energy in Q3 2020, an estimated $32.8M increase.
  • Moody Lynn & Lieberson's biggest Q3 2020 reduction was Microsoft, cutting an estimated $12.2M.
  • Moody Lynn & Lieberson fully exited Regeneron Pharmaceuticals in Q3 2020, selling an estimated $5.68M.
  • Moody Lynn & Lieberson's ten largest holdings make up 34% of its $1.01B portfolio in Q3 2020.
  • Moody Lynn & Lieberson opened 29 new positions and closed 20 in Q3 2020.
  • Moody Lynn & Lieberson's portfolio value rose 9.6% quarter-over-quarter to $1.01B.

Based on Moody Lynn & Lieberson's 13F filing for Q3 2020, filed 28 Oct 2020.